A5113065952- Lung Cancer Research Studies
- Cytomegalovirus and herpesvirus research
- Lymphoma Diagnosis and Treatment
- Neuroendocrine Tumor Research Advances
- Polyomavirus and related diseases
- IgG4-Related and Inflammatory Diseases
- Viral-associated cancers and disorders
- Viral Infections and Immunology Research
- Chronic Lymphocytic Leukemia Research
Seoul National University Hospital
2023-2025
Bispecific antibodies (BsAbs) are a new class of immunotherapeutic agents for patients with multiple myeloma (MM). Although this drug is associated good disease control, they also increased risk infectious complications. Since endemic community-acquired and nosocomial infections vary across the globe, we conducted study to report real-world data complications BsAbs in Korean population. We retrospectively reviewed all MM who received BsAb therapy between January 2021 2024 at Seoul National...
Inflammatory myofibroblastic tumor (IMT) is a rare entity, primarily affecting young individuals, often involving the abdomen, pelvis, or lung. Approximately 50% of IMTs harbor ALK gene rearrangements, making inhibitors viable treatment. We report case 40-year-old female with metastatic IMT harboring CARS1-ALK fusion. Initial chemotherapy failed, but targeted therapy alectinib through KOrean Precision Medicine Networking Group Study MOlecular profiling guided based on genomic alterations in...
Abstract Large granular lymphocytic (LGL) leukemia is a clonal lymphoproliferative disorder of LGLs derived from cytotoxic T lymphocytes or natural killer cells. However, the clinical features and treatment responses are still not fully understood because rarity disease. To describe assess cohort patients with T-cell large (T-LGLL). Single-center, retrospective, observational study. We retrospectively collected data diagnosed T-LGLL at Seoul National University Hospital since 2006. included...